Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

323 ARTÍCULOS , VIENDO DEL 46 AL 60

Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity

Jahanshad N, Rajagopalan P, Hua X, Hibar DP, Nir TM, Toga AW, Jack CR Jr, Saykin AJ, Green RC, Weiner MW, Medland SE, Montgomery GW, Hansell NK, McMahon KL, de Zubicaray GI, Martin NG, Wright MJ, Thompson PM; Alzheimer’s Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4768-73. doi: 10.1073/pnas.1216206110. Epub 2013 Mar 5.

Current progresses on nanodelivery systems for the treatment of neuropsychiatric diseases: Alzheimer's and schizophrenia

Silva AC, González-Mira E, Lobo JM, Amaral MH.

Curr Pharm Des. 2013;19(41):7185-95. doi: 10.2174/138161281941131219123329.

Is Alzheimer's a disease of the white matter?

Sachdev PS, Zhuang L, Braidy N, Wen W.

Curr Opin Psychiatry. 2013 May;26(3):244-51. doi: 10.1097/YCO.0b013e32835ed6e8.

Aspects of communication in Alzheimer's disease: clinical features and treatment options

Woodward M.

Int Psychogeriatr. 2013 Jun;25(6):877-85. doi: 10.1017/S1041610213000318. Epub 2013 Mar 25.

Meta-analysis of functional network alterations in Alzheimer's disease: toward a network biomarker

Jacobs HI, Radua J, Lückmann HC, Sack AT.

Neurosci Biobehav Rev. 2013 Jun;37(5):753-65. doi: 10.1016/j.neubiorev.2013.03.009. Epub 2013 Mar 21.

Technology-driven interventions for caregivers of persons with dementia: a systematic review

Godwin KM, Mills WL, Anderson JA, Kunik ME.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):216-22. doi: 10.1177/1533317513481091. Epub 2013 Mar 25.

Alzheimer's disease: connecting findings from graph theoretical studies of brain networks

Tijms BM, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F.

Neurobiol Aging. 2013 Aug;34(8):2023-36. doi: 10.1016/j.neurobiolaging.2013.02.020. Epub 2013 Mar 28.

Rivastigmine patch and massage for Alzheimer's disease patients

Satoh S, Kajiwara M, Kiyokawa E, Toukairin Y, Fujii M, Sasaki H.

Geriatr Gerontol Int. 2013 Apr;13(2):515-6. doi: 10.1111/ggi.12010.

Acute dystonic reaction with rivastigmine

Dhikav V, Anand KS.

Int Psychogeriatr. 2013 Aug;25(8):1385-6. doi: 10.1017/S104161021300029X. Epub 2013 Apr 8.

Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future

Geda YE, Schneider LS, Gitlin LN, Miller DS, Smith GS, Bell J, Evans J, Lee M, Porsteinsson A, Lanctôt KL, Rosenberg PB, Sultzer DL, Francis PT, Brodaty H, Padala PP, Onyike CU, Ortiz LA, Ancoli-Israel S, Bliwise DL, Martin JL, Vitiello MV, Yaffe K, Zee PC, Herrmann N, Sweet RA, Ballard C, Khin NA, Alfaro C, Murray PS, Schultz S, Lyketsos CG; Neuropsychiatric Syndromes Professional Interest Area of ISTAART.

Alzheimers Dement. 2013 Sep;9(5):602-8. doi: 10.1016/j.jalz.2012.12.001. Epub 2013 Apr 3.

Testing visual perception in dementia with Lewy bodies and Alzheimer disease

Wood JS, Firbank MJ, Mosimann UP, Watson R, Barber R, Blamire AM, O'Brien JT.

Am J Geriatr Psychiatry. 2013 Jun;21(6):501-8. doi: 10.1016/j.jagp.2012.11.015. Epub 2013 Jan 11.

[Aβ immunotherapy for Alzheimer's disease]

Sakai K, Yamada M.

Brain Nerve. 2013 Apr;65(4):461-8.

Vascular contribution to Alzheimer disease: predictors of rapid progression

Diomedi M, Misaggi G.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):532-7. doi: 10.2174/1871527311312040015.

Vascular endothelial growth factor gene promoter polymorphisms and Alzheimer's disease risk: a meta-analysis

Liu SY, Zeng FF, Chen ZW, Wang CY, Zhao B, Li KS.

CNS Neurosci Ther. 2013 Jul;19(7):469-76. doi: 10.1111/cns.12093. Epub 2013 Apr 10.

Diagnosis and management of Alzheimer's disease: past, present and future ethical issues

Gauthier S, Leuzy A, Racine E, Rosa-Neto P.

Prog Neurobiol. 2013 Nov;110:102-13. doi: 10.1016/j.pneurobio.2013.01.003. Epub 2013 Apr 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias